67 results
Page 2 of 4
424B7
qei ghf3nrp
3 Mar 22
Prospectus with selling stockholder info
4:43pm
F-3
akbzs7b hi9v
17 Feb 22
Shelf registration (foreign)
4:14pm
F-3
EX-4.1
bqkc4ay
17 Feb 22
Shelf registration (foreign)
4:14pm
6-K
EX-99.3
czmx6v
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
424B7
iadmo luqvvwwhnu
23 Nov 21
Prospectus with selling stockholder info
4:06pm
F-3
kix1ts6r415b3l2pnyrc
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K
EX-99.1
pjls 9b843a
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K/A
EX-99.2
jeobluaseouflys f1l0
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.5
z24 w4qoz
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
usj88pj8nvptyt29z2
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.5
qw0io4rs2eqekv7
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
s8w3 1c4vh766
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-1.1
4of9cu
5 Mar 21
Current report (foreign)
8:15am
424B5
w69lo
5 Mar 21
Prospectus supplement for primary offering
7:55am